These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11792747)

  • 41. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.
    Naldi L; Altieri A; Imberti GL; Giordano L; Gallus S; La Vecchia C;
    Ann Epidemiol; 2005 Aug; 15(7):545-50. PubMed ID: 16029848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder?
    Caporaso N; Greene MH; Tsai S; Pickle LW; Mulvihill JJ
    Cancer Genet Cytogenet; 1987 Feb; 24(2):299-314. PubMed ID: 3791179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous response to ultraviolet radiation-induced erythema in patients with type A dysplastic nevi.
    Aubin F; Manteaux A; Zultak M; Agache P
    Photodermatol Photoimmunol Photomed; 1991 Feb; 8(1):7-11. PubMed ID: 1768607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
    Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
    JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure.
    White E; Kirkpatrick CS; Lee JA
    Am J Epidemiol; 1994 May; 139(9):857-68. PubMed ID: 8166136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
    Goldstein AM; Martinez M; Tucker MA; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
    Augustsson A; Stierner U; Rosdahl I; Suurküla M
    Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study.
    Stierner U; Augustsson A; Rosdahl I; Suurküla M
    Melanoma Res; 1992; 1(5-6):367-75. PubMed ID: 1422192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA repair related to multiple skin cancers and drug use.
    Wei Q; Matanoski GM; Farmer ER; Hedayati MA; Grossman L
    Cancer Res; 1994 Jan; 54(2):437-40. PubMed ID: 8275480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residual dysplastic and other nevi in superficial spreading melanoma. Clinical correlations and association with sun damage.
    Black WC
    Cancer; 1988 Jul; 62(1):163-73. PubMed ID: 3383113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Malignant melanoma--a warning. How to reduce mortality?].
    Volden G; Rajka G; Thune P; Falk ES; Krogh HK
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1202-5. PubMed ID: 2333644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
    Goldstein AM; Goldin LR; Dracopoli NC; Clark WH; Tucker MA
    Am J Hum Genet; 1996 May; 58(5):1050-6. PubMed ID: 8651266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melanoma - role of the environment and genetics.
    Cust AE; Mishra K; Berwick M
    Photochem Photobiol Sci; 2018 Dec; 17(12):1853-1860. PubMed ID: 30113042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the interplay of telomeres, nevi and the risk of melanoma.
    Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
    PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients.
    Zhao C; Snellman E; Jansen CT; Hemminki K
    Int J Cancer; 2002 Mar; 98(3):331-4. PubMed ID: 11920582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light.
    Holly EA; Aston DA; Cress RD; Ahn DK; Kristiansen JJ
    Am J Epidemiol; 1995 May; 141(10):923-33. PubMed ID: 7741122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles.
    Bataille V; Snieder H; MacGregor AJ; Sasieni P; Spector TD
    J Natl Cancer Inst; 2000 Mar; 92(6):457-63. PubMed ID: 10716963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.